Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19492022 | 0.85 | USP30 (0.35) | CA1CA2CA7HDAC6HDAC1 | |
| SCHEMBL9019269 | 0.81 | HDAC6 (0.33) | CA1CA2CA7HDAC6HDAC1 | |
| SCHEMBL646682 | 0.78 | MEN1 (0.33) | CA1CA2CA7HDAC6HDAC1 | |
| SCHEMBL21964901 | 0.77 | CA1 (0.35) | CA1CA2CA7HDAC6HDAC1 | |
| SCHEMBL22221412 | 0.76 | MEN1 (0.32) | HDAC6HDAC1HDAC2 | |
| SCHEMBL20811333 | 0.76 | MEN1 (0.32) | HDAC6HDAC1HDAC2 | |
| SCHEMBL5204515 | 0.75 | CA14 (0.39) | CA1CA2CA7HDAC6HDAC1 | |
| SCHEMBL30279497 | 0.73 | MEN1 (0.30) | — | |
| SCHEMBL23107149 | 0.72 | CA1 (0.36) | CA1CA2CA7HDAC6HDAC1 | |
| SCHEMBL23773857 | 0.72 | CA1 (0.36) | CA1CA2CA7HDAC6HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220416303-A1 | FUNCTIONALIZED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | ORBIA FLUOR & ENERGY MATERIALS USA, INC. | 2022-12-29 | — | — | US | disclosed |